Interne Forschungsförderung durch die Forschungskommission

Bewilligte Anträge, 2016

Prof. Dr. Margitta Elvers, Institut für Hämostaseologie, Hämotherapie und Transfusionsmedizin:
Impact of platelets and red blood cells on thrombosis under conditions of hypox-ia: Mechanisms and consequences

Dr. Peter Göttle, Klinik für Neurologie
Development of new central nervous system regeneration therapy

2016/12 Dr. Sebastian M. Haberkorn, Klinik für Kardiologie, Pneumologie und Angiologie
Assessment of metabolic and structural alterations after myocardial infarction by MRI

2016/15 Dr. Jessica Höll, Klinik für Kinder-Onkologie, -Hämatologie und Klinische Im-munologie
The role of microRNAs in the development of prognostically favorable TCF3/PBX1-positive versus mostly fatal TCF3/HLF-positive pediatric acute lymphoblastic leukemias

2016/17 Prof. Dr. Verena Keitel-Anselmino, Klinik für Gastroenterologie, Hepatologie und Infektiologie
Inhibition of the signaling of the G-protein coupled bill acid sensing
receptor TGR5

2016/18 Dr. Christiane Knobbe-Thomsen, Institut für Neuropathologie
Characterization of Yap as a therapeutic target in diffuse gliomas

2016/22 Dr. Angela Manser, ITZ
Understanding the function of KIR3DL2 expression on CD4 T cells and its role in Sézary Syndrome

2016/25 Dr. Roland Piekorz, Institut für Biochemie und Molekularbiologie II
Characterisation of a novel extra-mitochondrial role of the stress-responsive and tumor suppressor protein SIRT4 in mitotic cell division

2016/27 Dr. Katharina Röllecke, Klinik für Hals-Nasen-Ohrenheilkunde
Development of CAR-T-cell therapy against head and neck squamous cell cancer for clinical applications with lentiviral vectors

2016/30 Prof. Dr. Stefanie Scheu, Institut für Medizinische Mikrobiologie und Krankenhaus-hygiene
Characterization of BATF functions in plasmacytoid dendritic cell development and type I IFN production

2016/36 Dr. Tatsiana Suvorava, Klinik für Kardiologie, Pneumologie und Angiologie
Role of red blood cells signaling in exercise-dependent cardiovascular protection

2016/38 Dr. Natascia Ventura, Zentralinstitut für Klinische Chemie und Laboratoriumsdiag-nostik
To exploit the anti-aging activity of lowering mitochondrial function as a tumor sup-pressor strategy

2016/41 Prof. Dr. rer. nat. Reiner Udo Jänicke, Kl. f. Strahlentherapie u. Radioonkologie
Regulation of p21WAF1/CIP1 expression by the RNA-binding proteins RBM47 and PTBP1 during DNA damage-induced stress responses

2016/44 Univ.-Prof. Dr. Judith Haendeler, Zentralinstitut für Klinische Chemie und Laboratoriumsdiagnostik und IUF - Leibniz Research Institute for Environmental Medicine; Prof. Dr. rer. nat. Heiner Schaal, Institut für Virologie;
Alternative and erroneous splicing in endothelial cells in response to cardiovascular risk factors and implications for endothelial functions

2016/46 Dr. med. Lisa Kristina Dannenberg, Kl. f. Kardiologie, Pneumologie u. Angiologie
Sources and kinetics of shingosine-1-phosphate in the acute and subacute phase of myocardial infarction in mice

2016/48 Prof. Dr. med. Carsten Korth, Inst. f. Neuropathologie
Novel molecular and cellular factors regulating proteostasis

2016/52 Dr. rer. sec. Jian Li, M.D., Ph.D., Inst. f. Arbeits-, Sozial- und Umweltmedizin;
Does a stressful psychosocial work environment affect cognitive decline? An initial study using a large longitudinal dataset in Germany

2016/53 Prof. Dr. med. Ellen Fritsche, Inst. f. Umweltmedizinische Forschung (IUF);
Exploration of the neurodevelopmental toxicity of novel flame retardants using human 3D in vitro models.

2016/55 Univ.-Prof. Dr. med. Heiner Fangerau, Inst. f. Geschichte, Theorie und Ethik der Medizin;
Europe and the Life Sciences: The Zoologische Station Neapel  as a catalyst of international cooperation in war and peace (1914-1945)

2016/56 Dr. Gabriel Leprivier, PhD Kl. f. Kinder-Onkologie, Hämatologie u.Kl. Immunologie
Deciphering the functions and regulation of 4EBP1 in neuroblastoma

 2016/60 Dr. med. Nora Weiduschat, Kl. f. Neurologie
Predicting visual pathway degeneration and disability after cerebral ischemia

2016/63 Prof. Dr. med. Ingo Drexler, Inst. f. Virologie;
The role of endogenous MHC class II presentation for CD4+ T cell responses in poxviral infection

2016/68 Dr. med. Dr. med. univ. Florian Babor, Kl. f. Kinder-Onkologie, Hämatologie u.Kl. Immunologie;
CD16xCD33 Bispecific Killer cell Engager (BiKE) and CD16xIL15xCD33 Trispecific Killer cell Engager (TriKE): novel immunotherapeutic antibodies against pediatric ALL and AML

2016/69 Prof. Dr. med. Hans H. Bock, Kl. f. Gastroenterologie, Hepatologie und Infektiologie;
Deciphering novel activation mechanisms of the signalling molecule Reelin and their relation to its pleiotropic physiological functions

2016/70 Dr. rer. nat. Ute Fischer, Kl. f. Kinder-Onkologie, Hämatologie u.Kl. Immunologie;
Impact of specific circular RNAs and their parental genes on leukemogenesis and treatment resistance of acute lymphoblastic leukemia

Stand Feb. 2017

Verantwortlich für den Inhalt: E-Mail sendenDekanat der Medizinischen Fakultät der HHU